Paper40796643
LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.
Blasco-Agell L and 19 others. Commun Biol, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model. Papers, record 40796643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40796643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Major topic |
| Induced Pluripotent Stem Cells | Major topic |
| Melanins | Major topic |
| Parkinson Disease | Major topic |
| Microglia | Major topic |
| Dopaminergic Neurons | Major topic |
| Mutation | Major topic |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PID2019-108792GB-I00 | Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) | PubMed | ||
| PID2022-137963OB-I00 | Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) | PubMed | ||
| 202012-32 | Fundació la Marató de TV3 (TV3 Marathon Foundation) | PubMed |
Source PubMed
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26365310 | LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. | Nat Commun | 2015 | https://conductscience.org/library/papers/26365310 | PubMed |
| 2 | 2575832 | Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease. | Acta Neurol Scand Suppl | 1989 | https://conductscience.org/library/papers/2575832 | PubMed |
| 3 | 19214748 | Interleukin-6 serum levels in patients with Parkinson's disease. | Neurochem Res | 2009 | https://conductscience.org/library/papers/19214748 | PubMed |
| 4 | 20921534 | LRRK2 is involved in the IFN-gamma response and host response to pathogens. | J Immunol | 2010 | https://conductscience.org/library/papers/20921534 | PubMed |
| 5 | 16219675 | A possible role for humoral immunity in the pathogenesis of Parkinson's disease. | Brain | 2005 | https://conductscience.org/library/papers/16219675 | PubMed |
| 6 | 28780180 | Neuropathology of Parkinson disease. | Parkinsonism Relat Disord | 2018 | https://conductscience.org/library/papers/28780180 | PubMed |
| 7 | 11205147 | Changes in cytokines and neurotrophins in Parkinson's disease. | J Neural Transm Suppl | 2000 | https://conductscience.org/library/papers/11205147 | PubMed |
| 8 | 19252484 | Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. | Nat Biotechnol | 2009 | https://conductscience.org/library/papers/19252484 | PubMed |
| 9 | 19732964 | Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease. | J Neuroimmunol | 2009 | https://conductscience.org/library/papers/19732964 | PubMed |
| 10 | 28649611 | LRRK2 levels in immune cells are increased in Parkinson's disease. | NPJ Parkinsons Dis | 2017 | https://conductscience.org/library/papers/28649611 | PubMed |
| 11 | 23573196 | Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions. | PLoS One | 2013 | https://conductscience.org/library/papers/23573196 | PubMed |
| 12 | 19487152 | [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? | Parkinsonism Relat Disord | 2010 | https://conductscience.org/library/papers/19487152 | PubMed |
| 13 | 19957214 | Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. | Neurotox Res | 2011 | https://conductscience.org/library/papers/19957214 | PubMed |
| 14 | 1494900 | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? | J Neurochem | 1992 | https://conductscience.org/library/papers/1494900 | PubMed |
| 15 | 29800472 | Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. | Brain | 2018 | https://conductscience.org/library/papers/29800472 | PubMed |
| 16 | 28257086 | High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28257086 | PubMed |
| 17 | 28489815 | Common genetic variation drives molecular heterogeneity in human iPSCs. | Nature | 2017 | https://conductscience.org/library/papers/28489815 | PubMed |
| 18 | 21778362 | Synaptic pruning by microglia is necessary for normal brain development. | Science | 2011 | https://conductscience.org/library/papers/21778362 | PubMed |
| 19 | 31251435 | Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease. | Mov Disord | 2019 | https://conductscience.org/library/papers/31251435 | PubMed |
| 20 | 29443098 | A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes. | J Vis Exp | 2018 | https://conductscience.org/library/papers/29443098 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42726290 | Molecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer's vulnerability. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42726290 | PubMed |
| 42140967 | α-Synuclein aggregates induce mitochondrial damage and trigger innate immunity to drive neuron-microglia communication. | Nat Commun | 2026 | https://conductscience.org/library/papers/42140967 | PubMed |
| 42101666 | Using iPSC models to examine neuron-glia interactions in neurodegenerative diseases. | Biosci Rep | 2026 | https://conductscience.org/library/papers/42101666 | PubMed |
| 41851867 | Inflammatory signaling differentially changes chromatin accessibility and gene expression of the PD- associated kinase LRRK2 between human and mice. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/41851867 | PubMed |
| 41820341 | Impaired α -Synuclein aggregate clearance in neuronal cells drive their spread to microglia through tunneling nanotubes. | Nat Commun | 2026 | https://conductscience.org/library/papers/41820341 | PubMed |
| 41648127 | Inflammatory signaling differentially changes chromatin accessibility and gene expression of the PD- associated kinase LRRK2 between human and mice. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648127 | PubMed |
| 41465422 | Glial Cells in the Early Stages of Neurodegeneration: Pathogenesis and Therapeutic Targets. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465422 | PubMed |
| 41460324 | Revisiting the alpha-synuclein paradox in melanoma-Parkinson's disease connection: more than a tale of two cell fates. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/41460324 | PubMed |
| 41278831 | Impact of Alzheimer's disease risk factors and local neuromelanin content on the transcriptomic landscape of the human locus coeruleus. | bioRxiv | 2025 | https://conductscience.org/library/papers/41278831 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GNE | 10020 | PubTator's text mining | https://conductscience.org/library/genes/10020 | NCBI Gene |
| LRRK2 | 120892 | PubTator's text mining | https://conductscience.org/library/genes/120892 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40796643
GET https://conductscience.org/api/papers/v1/40796643/references?page=2